Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials

1999/01/01 by Stefan Leucht, S. Leucht, Gabriele Pitschel‐Walz +5 · 9 citations
Medicine · #Bipolar Disorder and Treatment #Epilepsy research and treatment #Schizophrenia research and treatment

paper · doi:10.1016/s0920-9964(98)00105-4

openalex publication_date 1999/01/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/30

Citations

• The Brief Psychiatric Rating Scale
• Treatment of Schizophrenia
• A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS

Cited by

• Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
• Amphetamine-induced psychosis - a separate diagnostic entity or primary psychosis triggered in the vulnerable?
• Treatment for amphetamine psychosis
• Why Olanzapine Beats Risperidone, Risperidone Beats Quetiapine, and Quetiapine Beats Olanzapine: An Exploratory Analysis of Head-to-Head Comparison Studies of Second-Generation Antipsychotics
• Typical and Atypical Antipsychotics – The Misleading Dichotomy
• How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials
• How CATIE brought us back to Kansas: a critical re-evaluation of the concept of atypical antipsychotics and their place in the treatment of schizophrenia
• Happy birthday neuroleptics! 50 years later: la folie du doute
• Efficacy of risperidone versus olanzapine in patients with schizophrenia previously on chronic conventional antipsychotic therapy: A switch study